Apr 3
|
Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 27
|
Mereo BioPharma Group PLC (MREO) Announces Full Year 2023 Financial Results
|
Mar 27
|
Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update
|
Mar 5
|
Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference
|
Dec 19
|
Hedge Funds Say These Penny Stocks Are Poised to Explode
|
Oct 14
|
Ultragenyx and Mereo BioPharma Announce Interim Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Setrusumab (UX143) Significantly Reduced Fracture Rates in Patients with Osteogenesis Imperfecta (OI)
|